/Companies

Vesica Health

Irvine, US · Founded 2022 · Delaware corporation

Find your way into Vesica Health

Sign up to see every warm intro you have to Vesica Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vesica Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.

Founders & leadership

CTChristopher Thibodeau
Christopher ThibodeauExecutiveChristopher Thibodeau is an executive with 28 years of experience in molecular diagnostics and oncology, with expertise in NGS, machine learning, regulatory pathways, and commercialization of diagnostic assays across U.S. and European markets. He is Executive Officer and Director at Vesica Health.
LCLaura Caba
Laura CabaExecutive

Board

JG
Jan GroenBoard director
MM
Mark McDonoughBoard director
JS
Joseph SolleeBoard director

Reported raises · per SEC filings

Form D private placements

$4.5M disclosed across 1 round · 2026

▶$4.5MraisedMar 2026 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher ThibodeauExecutive Officer, Director
  • Jan GroenDirector
  • Mark McDonoughDirector
  • Joseph SolleeDirector
  • Laura CabaExecutive Officer
Offering amount
$4.6M
Amount sold
$4.5M
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Vesica Health.

Frequently asked questions

What does Vesica Health do?
Vesica Health develops AssureMDx, a noninvasive urine-based genomic test that analyzes DNA methylation and somatic mutation biomarkers to assess bladder cancer risk in patients presenting with hematuria. The test helps primary care physicians and urologists triage patients for referral, avoid unnecessary invasive procedures, and support early detection of bladder cancer.
How much funding has Vesica Health raised?
Vesica Health has disclosed $4.5M raised across 1 round.
Where is Vesica Health headquartered?
Vesica Health is headquartered in Irvine, US.